Clin2
NCT07171034Likely a fitRecruiting

Testing KLA318-2 in healthy volunteers

Healthy Participants

This study tests a new drug called KLA318-2 in healthy volunteers to see how it is processed by the body and how safe it is. It is a first-in-human trial, so it helps find the right dose and check for any side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
48 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are between 18 and 45 years old.
  • You weigh at least 50 kg (if male) or 45 kg (if female) and your BMI is between 18.5 and 28.
  • You have no known allergies or drug hypersensitivity, and no significant medical conditions.
  • You have not taken any prescription or over-the-counter drugs in the last 14 days, and no vaccines in the last month.
  • You do not smoke heavily (more than 3 cigarettes/day) or drink heavily (more than 14 drinks/week).
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07412288Recruiting· Phase 1
Safety study of KT-579 in healthy volunteers

This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.

Lincoln, Nebraska
NCT07448155Recruiting· Phase 1
Testing a new drug in healthy volunteers

This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.

Tempe, Arizona
NCT07823205Recruiting· Phase 1
Oral KT-621 study for healthy volunteers

This trial tests a new oral medication, KT-621, given as different tablet or capsule forms. It helps researchers understand how the body handles the drug, which is the first step toward future treatments.

Lincoln, Nebraska
NCT07143318Recruiting· Phase 1
First-in-Human study of KLA578-1 for injection in healthy volunteers

This trial tests a new investigational drug for the first time in people. It will study how the drug is processed by the body in healthy volunteers. If you are a generally healthy adult, you may be able to help with this important early research.

Changsha, Hunan
NCT07240675Recruiting· Phase 1
First-in-human safety study of KLA478 in healthy volunteers

This study tests a new drug called KLA478 for the first time in humans. It is looking for healthy volunteers to see how the drug affects the body and how safe it is.

Shanghai, Shanghai Municipality
NCT07829406Not yet recruiting· Phase 1
Safety study of a new medicine in healthy adults

This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.

Salt Lake City, Utah

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.